COMP <GO>
CCM vs DCGO // EV/EBITDA & P/E VALUATION
Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A) (NYSE) VS. DocGo Inc. (NASDAQ) • 15-METRIC TALLY: CCM 3
— DCGO 3
■ METRIC PARITY
CCM — Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A)
ROARABLE E • RQD 22/100
LAST: $3.66 (-4.93%) • MKT CAP: $15.9M
valuation
—
LAST: $0.27 (-2.43%) • MKT CAP: $27.0M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CCM VS. DCGO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CCM | DCGO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 5.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -57.60% | -55.30% | -2.30 | DCGO | /operating-margins <GO> |
| Net Profit Margin | -20.40% | -60.00% | +39.60 | CCM | /net-margins <GO> |
| Revenue Growth (YoY) | 26.60% | -47.70% | +74.30 | CCM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 5/9 | -3.00 | DCGO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.6 | 31.3 | +16.33 | CCM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.9M | $27.0M | -$11.1M | DCGO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CCM REV | DCGO REV | CCM GROSS % | DCGO GROSS % | CCM FCF | DCGO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $65.0M | $322.2M | 5.7% | — | -$36.9M | $29.9M |
| FY 2024 | $51.3M | $616.6M | -21.1% | — | -$75.1M | $66.5M |
| FY 2023 | $73.3M | $624.3M | — | — | -$38.9M | -$64.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CCM // BETA —
DCGO // BETA —